GIPR/GLP-1R dual agonist therapies for diabetes and weight loss—chemistry, physiology, and clinical...
In this review, Campbell et al. discuss the development of multi-receptor therapeutics that target incretin receptors to improve glycemic control and induce weight loss. This is a 20-year perspective...
cell.com